No active shortage notice linked to this record. No active shortage notice is linked to this Nystatin 5Bu record from the regulators Mederti tracks. Countries without a data source are not covered, and some regulators file notices under salt or local-language names, so absence of a notice is not confirmation of supply.
No active shortage notice is currently linked to Nystatin 5Bu in Mederti's data from the national medicines regulators it tracks. Some regulators list notices under a salt or local-language name, so check the relevant country register too. Shortages can emerge quickly — this page updates daily from official sources.
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountMederti is an independent information service that aggregates notices published by official national medicines regulators, checked daily. It is not a regulator and is not affiliated with or endorsed by any regulator. A regulator's shortage status does not confirm or rule out commercial stock at any pharmacy or wholesaler. This page is not clinical advice; check the official notice and consult a pharmacist or prescriber before changing treatment.